Tokyo Tape
Sign in
← Oncolys BioPharma

Quarterly report · Q2

4588.TEDINET S100OV5V
Period2022-01-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥426m2022-01-01 → 2022-06-30StandaloneNet sales
Revenue¥642m2021-01-01 → 2021-12-31StandaloneNet sales (5-year summary)
Revenue¥193m2021-01-01 → 2021-06-30StandaloneNet sales
Operating income−¥659m2022-01-01 → 2022-06-30StandaloneOperating income
Operating income−¥634m2021-01-01 → 2021-06-30StandaloneOperating income
Ordinary income−¥591m2022-01-01 → 2022-06-30StandaloneOrdinary income
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥649m2021-01-01 → 2021-06-30StandaloneOrdinary income
Profit before tax−¥569m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Profit before tax−¥649m2021-01-01 → 2021-06-30StandaloneIncome before income taxes
Net income−¥571m2022-01-01 → 2022-06-30StandaloneProfit loss
Net income−¥1.6bn2021-01-01 → 2021-12-31StandaloneNet income loss (5-year summary)
Net income−¥651m2021-01-01 → 2021-06-30StandaloneProfit loss
Total assets¥3.5bnat 2022-06-30StandaloneAssets
Total assets¥4.3bnat 2021-12-31StandaloneAssets
Total assets¥5.2bnat 2021-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥767mat 2022-06-30StandaloneLiabilities
Total liabilities¥698mat 2021-12-31StandaloneLiabilities
Net assets / equity¥2.7bnat 2022-06-30StandaloneNet assets
Net assets / equity¥3.6bnat 2021-12-31StandaloneNet assets
Net assets / equity¥4.5bnat 2021-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥2.9bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥3.5bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥2.6bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥4.4bnat 2021-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2020-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥722m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥595m2021-01-01 → 2021-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥21m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥942,0002021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥327,0002021-01-01 → 2021-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥30m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.1bn2021-01-01 → 2021-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-32.922022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.942022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-39.452021-01-01 → 2021-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-17.352021-04-01 → 2021-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio77.9%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio86.1%at 2021-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued17,405,200at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,340,900at 2021-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 451
ItemContextValueUnit
Net assetsCurrentQuarterInstant_NonConsolidatedMember2737637000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4291876000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember3504831000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember193067000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember426152000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember53516000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember186697000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember139551000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember239454000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember773150000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember898353000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-633599000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-658898000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember238000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember284000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember24514000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember84344000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember685000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember12000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember25437000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember84641000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember2109000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember1937000JPY
Amortization of restricted stock remuneration noePrior1YTDDuration_NonConsolidatedMember27135000JPY
Amortization of restricted stock remuneration noeCurrentYTDDuration_NonConsolidatedMember14289000JPY
Share acquisition rights issuance costs noePrior1YTDDuration_NonConsolidatedMember413000JPY
Share acquisition rights issuance costs noeCurrentYTDDuration_NonConsolidatedMember－JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember10977000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember30000JPY
Other noePrior1YTDDuration_NonConsolidatedMember217000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember0JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember40853000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember16257000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-649015000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-590514000JPY
Gains on sales of bonds eiPrior1YTDDuration_NonConsolidatedMember－JPY
Gains on sales of bonds eiCurrentYTDDuration_NonConsolidatedMember21406000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember－JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember21406000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-649015000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-569108000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember1844000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1461000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember1844000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1461000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-650860000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-570569000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-649015000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-569108000JPY
Depreciation and amortization ope cfPrior1YTDDuration_NonConsolidatedMember3054000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass